Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma.

Jia WangJie ZuoMao-De WangWan-Fu XieXiao-Bin BaiXu-Dong Ma

Published in: CNS neuroscience & therapeutics (2019)

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma, CNS Neuroscience & Therapeutics 2019, (https://doi.org/10.1111/cns.13227). The above article published online on 02 October 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor in Chief Jun Chen, and John Wiley & Sons Ltd. The retraction has been agreed due to unreliable data and consequently its misleading results and conclusions.

Keyphrases

tyrosine kinase
poor prognosis
long non coding rna
epidermal growth factor receptor
social media
health information
blood brain barrier
newly diagnosed
electronic health record
small molecule
healthcare
binding protein
systematic review
big data
machine learning
deep learning